-
2024-518871-74-00
4
Locally Advanced or Metastatic Solid Tumours that harbour MET Amplific
-
2024-519529-40-00
5
ESOPHAGOYEJUNAL ANASTOMOSIS DEHISCENCE IN TOTAL GASTRECTOMIES FOR CANC
-
2024-519673-18-00
4
Patients with localized renal cell carcinoma
-
2024-519786-22-01
9
metastatic non-small cell lung cancer (NSCLC)
-
2024-519818-31-01
5
Endometrial Cancer
Advanced, Recurrent, Metastatic, or Primary Unresec
-
2024-519994-20-00
5
Agitation Associated with Alzheimer’s Disease
-
2025-520471-29-00
5
Locally advanced adenocarcinoma of the colon and upper rectum with mic
-
2025-520565-51-00
5
small cell lung cancer
-
2025-521062-10-00
1
KRAS G12D Mutated Advanced Solid Tumors
-
2025-521113-13-00
10
Early Parkinson’s Disease
-
2025-521209-42-00
6
advanced colorectal cancer with wild-type RAS and right primary tumour
-
2025-521221-32-00
5
Advanced or Metastatic Non-Small Cell Lung Cancer
-
2025-521590-13-00
5
Moderately to Severely Active Crohn’s Disease
-
2025-521709-42-00
5
Allergic rhinoconjunctivitis with or without asthma due to clinically
-
2025-521736-10-00
5
Allergic rhinoconjunctivitis with or without controlled asthma
-
2025-521902-17-00
9
Unresectable/metastatic Small cell Lung Cancer (SCLC)
-
2025-521981-90-00
1
Advanced Solid Tumors
-
2025-522406-20-00
9
Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
-
2025-522475-28-00
5
Pulmonary Hypertension (PH) with Heart Failure with preserved left ven
-
2025-522523-96-00
1
T-cell Non-Hodgkin Lymphoma
-
2025-522552-20-00
5
Lennox-Gastaut Syndrome
-
2025-522848-40-00
6
Early Breast Cancer
-
2025-522855-25-00
5
Carcinoma, Transitional Cell
-
2025-522904-26-00
3
Systemic Lupus Erythematosus (SLE) With or Without Active Lupus Nephri